Abstract
Early recognition of hypertensive heart disease is needed to prevent macrovascular and microvascular damage. Hypertension (HTN) is a risk factor for coronary artery disease, and plays a prominent role in the development of adverse left ventricular (LV) remodeling and heart failure. Here, we review new knowledge on effects of HTN on cardiac geometry and function, obtained from multimodality cardiac imaging, including echocardiography, positron emission tomography and magnetic resonance imaging. Early recognition of changes in LV geometry and function induced by HTN could identify patients at risk for end-organ damage, who could be targeted for close monitoring and intensive therapy. Basal septal hypertrophy as the early imaging biomarker at the adaptive phase may be a specific aspect not only in hypertensive heart but stress-related conditions and called stressed heart morphology.
Keywords: Hypertension, basal septal hypertrophy, adaptive phase, stressed heart morphology, echocardiography
Introduction
Chronic pressure overload caused by hypertension induces increase in LV wall thickness to normalize wall stress. In the early stage, increase in relative wall thickness before development of hypertrophy (LVH) is associated with preservation of left ventricular (LV) function. Over time, pressure-overload leads to concentric remodeling of the LV, which reduces wall stress and preserves pump function despite abnormalities in cardiac mechanics [1]. In the setting of uncontrolled HTN, progressive increase in wall thickness occurs, which manifests as LVH on cardiac imaging. Concomitantly, HTN lead to macrovascular and microvascular disease, which contribute to the development of heart failure [2,3]. Chronic pressure-overload leads to increase in wall stress and increase in LV myocardial mass which is associated with adverse cardiovascular (CV) events and all-cause mortality [4]. However, effective medication can reduce LVH and CV death, myocardial infarction, stroke [5,6].
Echocardiography
Echocardiography have provided great contribution to diagnose and follow-up of cardiac patients with development of treatment modalities since the basic ultrasound principals have been used practically and effectively. Unique diagnostic contribution of echocardiography in cardiology have continuously increased by the technic developments including blood flow and tissue Doppler, speckle tracking, strain imaging and real-time 3 dimensional echocardiography (RT3DE) which are being used widespreadly [7,8].
Focal hypertrophy may be an early finding in LV geometric remodelling in hypertensive patients. It was shown that septal base is thicker than mid apical part in mild and moderate HTN [9]. Histologic features of septal base was found different from hypertrophic cardiomyopathy. On an autopsy performed in a patient, the hypertrophy was identified, although results of microscopic examination showed no fibre disarray as seen in primary cardiomyopathy [10]. We previously observed a decreased LV basal cavity volume possibly due to basal hypertrophic segment in patients with hypertensive LVH using RT3DE [11].
It was suggested that differently from primary cardiomyopathy the focal hypertrophy may be secondary or contributory to the enhanced ventricular dynamics [12]. In earlier stage of hypertensive disease than LVH, we previously detected stress-induced increased LV outflow tract gradients in hypertensives with basal septal hypertrophy (BSH) [13]. Beta-blocker therapy may be beneficial for dynamic LV outflow tract obstruction in hypertensive BSH [14]. To resolve obstruction caused by striking hypertensive BSH, even alcohol septal ablation was used successfully [15]. In hypertensive BSH, we quantitatively detected the stress-induced hypercontractility on focal hypertrophied septal base by tissue Doppler imaging combined with dobutamine stress [16]. Therefore, it is usually accepted that hypercontractility is detected in HTN earlier than LVH and tissue dysfunction [17].
Similar to our documented findings in BSH [16,18], stress-induced hypercontractility is also usual finding in patients with global hypertrophy and it may result in a diagnostic dilemma for coronary artery disease [19]. It was demonstrated using microneurography and isotope dilution methodology that increased sympathetic activity is directly related to the development of hypertensive LVH [20]. Stress-induced hypercontractility may be a reflection of preserved LV function in hypertensive LVH [21]. In fact, we observed that complex mitral annulus geometry and dynamics which reflect systolic function are preserved in patients with hypertensive patients with global hypertrophy by RT3DE [22].
Furthermore, we mentioned the importance of precise LV contractility evaluation and quantitative volume determination by cardiac imaging in HTN [23]. It was suggested that hypercontractility with LV cavity obliteration may be associated with a good prognosis [24]. Hypercontractility of LV base also was described in stress-induced cardiomyopathy [25]. Since this region is more predominant and hypercontractile in both HTN and acute stress cardiomyopathy, we have suggested that stressed heart morphology (SHM) related to predominant LV base may be a conjunctive point of determination in clinical conditions with acute or chronic stress exposure due to increased afterload [18,26,27]. This variety of stress-related conditions could be together with the different etiologic components including emotional, functional due to increased vascular tonus and mechanic blockage due to stenotic valve diseases as discussed in the SHM section of the current review.
3rd generation microscopic ultrasonography
Hypertensive LVH may have regional heterogeneity. Early determination of hypertensive heart disease using biomarkers could be valuable to start early antihypertensive medication which could prevent adverse disease consequences [28-31]. We documented that BSH (Figure 1) is an early imaging marker of hypertrophy using 3rd generation microscopic ultrasonography in an animal model [31]. The LV septal base may be the first affected region since LV cavity diameter is greatest at the base, resulting in greater wall stress, when compared to the mid and apical regions [32]. Furthermore, studies have demonstrated greater sympathetic innervation of the LV base compared to the apex. The LV base (Figure 2) also has greater tissue content of noradrenaline which could be related to the myocardial dynamics [33,34]. Early septal involvement in turn could result in greater degree of tissue dysfunction in the basal septum compared to LV free wall in advance hypertensive disease [35].
Figure 1.
Cardiac images of a mice using 3rd generation microscopic ultrasound show normal cardiac geometry, relatively prominent LV septal base at 4 week after stress induction due to pressure-overload (TAC: transverse aortic construction) and global remodeling at 8 week, respectively.
Figure 2.

Parasternal long-axis echocardiography shows a predominant regional LV septal base during end-diastole in a hypertensive patient with basal septal hypertrophy.
Therefore, any delay in effective treatment may lead to a progression in LV remodeling. Notably, hypertensive remodeling in patients treated with antihypertensives is associated with increased likelihood of adverse CV events independent of age, gender, blood pressure lowering treatment modality, and in-treatment LV mass index [36]. RT3DE reconstruction data can provide a global geometric assessment in the hypertensive disease process. We and others have previously documented regional LV geometric heterogeneity and diminished LV basal cavity volume which is a consistent finding with predominant LV septal base in secondary LVH using RT3DE [11,37].
Early documentation of the remodeling in HTN has gained more importance, because this is a reflection of early cardiac end-organ change, which could identify patients needing intense BP monitoring and treatment [38-43]. It was reported that marked elevations of BP during exercise, even in the absence of resting HTN is associated with increased LV mass [38]. We suggested that exercise HTN (greater BP than 210 mmHg in men, 190 mmHg in women) [38], may be common in otherwise healthy, young adults, can be of clinical importance [39]. It should be considered as a cause of what could otherwise be considered to be physiologic LV remodeling detected by cardiac magnetic resonance (CMR) [40]. Blood pressure trends during exercise may have prognostic information even in healthy subjects and identify individuals at risk for target organ damage, including LVH, in patients without HTN diagnosis [41,42]. These individuals who would not be classified as hypertensive by conventional standards could undergo additional evaluation, include sleep study to rule out sleep apnea, lifestyle modifications (e.g. weight loss) to prevent development of overt HTN, as well as cardiac imaging and renal function testing to detect the presence of target organ damage [43].
Stress such as exercise, which increases blood pressure can be informative in clinical practice [23,43]. In the early stage of hypertensive heart disease, we and the others reported that HTN-mediated early focal hypertrophy could be a part of clinical spectrum in hypertensive heart disease [9,10,13,14,16]. Regional LV functional analysis can be detectable quantitatively using novel cardiac imaging including tissue Doppler, strain and combined stress test and tissue Doppler imaging [9,13,16,18,21,23,26]. Furthermore, determination of exercise HTN in patients with undiagnosed HTN [42] or incidentally detected BSH [13,16] could be important for early recognition of subclinical target organ damage.
Stressed heart morphology
Early LV remodeling detected by CMR due to exercise hypertension are being more evaluated in healthy individuals including endurance athletes [39,40,44-46]. Stress test with BP monitoring may be recommended especially for the individuals who look healthy and have SHM (predominant septal base with/without hypercontractility at peak stress) to eliminate exercise HTN [45]. Beyond increased arteriolar tonus in hypertension as functional and acute stress cardiomyopathy as emotional etiology, we recently have described SHM in patients with aortic stenosis as mechanic etiology [46] and discussed the special sensitivity of septal base to the variety of stress stimuli [16-18,25-27,35,39,40,45,46].
LV compensatory hyperfunction in patients with chest pain without any coronary artery disease was more common in patients with hypertension in wall motion analysis [47]. In mild HTN, endocardial fiber shortening as LV functional parameter to end-systolic stress was shown to be associated with enhanced ventricular contractility [48]. LV hyperfunction in higher ambulatory blood pressure was found along with a greater velocity of fiber shortening in relation to end-systolic wall stress [17]. Stress-induced LV hyperfunction could be an early component of LV remodeling even in borderline HTN [49]. However, segmental detection of LV remodeling progression geometric and functionally in humans could be challenging.
In fact, we detected a tissue velocity increment at early remodeling with BSH in small animals with pressure-overload which was consistent with the findings in humans (Figure 3) and a sharp transition from compensatory hyperfunction to tissue dysfunction by 3rd generation microscopic ultrasonography [31,50]. In this animal validation study, we noted imaging aspects of this transition from compensatory LV hyperfunction with development of BSH and increased gradients to maladaptive global remodeling with low gradients during the adaptive and maladaptive phases of LV remodeling under hemodynamic stress.
Figure 3.

Remarkable protrudition of septal basal tissue into the LV outflow tract during end-systole in the same patient of Figure 2.
Radionuclide myocardial perfusion imaging
Increased O2 uptake with exercise HTN in normotensive individuals at rest was determined by first-pass radionuclide angiography about three decades ago [51]. In that study, LV hyperfunction plotted consistent findings with the wall motion analyses in patients with HTN. LV hyperfunction under stress induction could be detected in patients with dyspnea and considered to be related to diastolic dysfunction in radionuclide myocardial perfusion imaging [52]. However, any study neglecting existence of exercise HTN could not plot such a conclusion in patients with LV hyperfunction under stress [53].
Fibrosis and magnetic resonance imaging
Regional tissue Doppler evaluation can contribute to detect segmental dysfunction [54] or segmental wall motion abnormality which is reported to be a sign of adverse outcome in patients with HTN [36]. Hypertensive patients without global remodeling was found to have lower myocardial extracellular volume than that in patients with hypertensive LVH who have blunted myocardial strain on CMR [55]. Microcirculation and myocardial structure are altered with progression of hypertensive heart disease, apoptosis and fibrosis lead to reduced LV contractility [56]. Because fibrosis-mediated abnormalities in hypertensive heart disease course are important, development of fibrosis in hypertensive LV remodeling was pointed out as the therapeutical target [57,58]. The older hypertensive patients with a mean age of 70 are associated with the blunted response of myocardial tissue to stress induction [59].
It was demonstrated that a significant degree of improvement in midwall or endocardial wall fractional shortening can be achieved by aggressive antihypertensive treatment leading to a reduction of observed CV events and the incidence of heart failure [60]. Although effective antihypertensive treatment is essential to improve LV function and better outcome, fibrosis markers related to aging process are associated with multiple adverse cardiac outcomes including myocardial infarction, heart failure, and death are significantly elevated [61,62].
Conclusion
Basal septal hypertrophy with LV hyperfunction under stress both in animal model and humans is detectable by novel quantitative cardiac imaging methods and represents the early adaptive phase of LV remodeling prior to maladaptation. Novel geometric and functional imaging findings in the adaptive phase of hypertensive heart may be a conjunctive point of determination in stress-mediated cardiac conditions and called SHM.
Acknowledgements
We acknowledge FY is supported by TÜBİTAK (Turkish Scientific and Technical Research Council), Ankara, Turkiye.
Disclosure of conflict of interest
None.
References
- 1.Sadler DB, Aurigemma GP, Williams DW, Reda DJ, Materson BJ, Gottdiener JS. Systolic function in hypertensive men with concentric remodeling. Hypertension. 1997;30:777–781. doi: 10.1161/01.hyp.30.4.777. [DOI] [PubMed] [Google Scholar]
- 2.de Simone G, Devereux RB, Koren MJ, Mensah GA, Casale PN, Laragh JH. Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation. 1996;93:259–265. doi: 10.1161/01.cir.93.2.259. [DOI] [PubMed] [Google Scholar]
- 3.Bigi R, Bestetti A, Strinchini A, Conte A, Gregori D, Brusoni B, Fiorentini C. Combined assessment of left ventricular perfusion and function by gated single-photon emission computed tomography for the risk stratification of high-risk hypertensive patients. J Hypertens. 2006;24:767–773. doi: 10.1097/01.hjh.0000217861.12617.33. [DOI] [PubMed] [Google Scholar]
- 4.Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension. 2000;35:580–586. doi: 10.1161/01.hyp.35.2.580. [DOI] [PubMed] [Google Scholar]
- 5.Aurigemma GP, Williams D, Gaasch WH, Reda DJ, Materson BJ, Gottdiener JS. Ventricular and myocardial function following treatment of hypertension. Am J Cardiol. 2001;87:732–736. doi: 10.1016/s0002-9149(00)01492-2. [DOI] [PubMed] [Google Scholar]
- 6.Devereux RB, Alderman MH. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation. 1993;88:1444–1455. doi: 10.1161/01.cir.88.4.1444. [DOI] [PubMed] [Google Scholar]
- 7.Feigenbaum H. Role of M-mode technique in today’s echocardiography. J Am Soc Echocardiogr. 2010;23:240–257. 335–7. doi: 10.1016/j.echo.2010.01.015. [DOI] [PubMed] [Google Scholar]
- 8.Jan MF, Tajik AJ. Modern imaging techniques in cardiomyopathies. Circ Res. 2017;121:874–891. doi: 10.1161/CIRCRESAHA.117.309600. [DOI] [PubMed] [Google Scholar]
- 9.Baltabaeva A, Marciniak M, Bijnens B, Moggridge J, He FJ, Antonios TF, MacGregor GA, Sutherland GR. Regional left ventricular deformation and geometry analysis provides insights in myocardial remodelling in mild to moderate hypertension. Eur J Echocardiogr. 2008;9:501–508. doi: 10.1016/j.euje.2007.08.004. [DOI] [PubMed] [Google Scholar]
- 10.Belenkie I, MacDonald RP, Smith ER. Localized septal hypertrophy: part of the spectrum of hypertrophic cardiomyopathy or an incidental echocardiographic finding? Am Heart J. 1988;115:385–390. doi: 10.1016/0002-8703(88)90486-3. [DOI] [PubMed] [Google Scholar]
- 11.Yalcin F, Shiota T, Odabashian J, Agler D, Greenberg NL, Garcia MJ, Lever HM, Thomas JD. Comparison by real-time three-dimensional echocardiography of left ventricular geometry in hypertrophic cardiomyopathy versus secondary left ventricular hypertrophy. Am J Cardiol. 2000;85:1035–1038. doi: 10.1016/s0002-9149(99)00929-7. [DOI] [PubMed] [Google Scholar]
- 12.Krasnow N. Subaortic septal bulge simulates hypertrophic cardiomyopathy by angulation of the septum with age, independent of focal hypertrophy. An echocardiographic study. J Am Soc Echocardiogr. 1997;10:545–555. doi: 10.1016/s0894-7317(97)70009-9. [DOI] [PubMed] [Google Scholar]
- 13.Yalcin F, Muderrisoglu H, Korkmaz ME, Ozin B, Baltali M, Yigit F. The effect of dobutamine stress on left ventricular outflow tract gradients in hypertensive patients with basal septal hypertrophy. Angiology. 2004;55:295–301. doi: 10.1177/000331970405500309. [DOI] [PubMed] [Google Scholar]
- 14.Al-Nasser F, Duncan A, Sharma R, O’Sullivan C, Coats AJ, Anker SD, Henein MY. Beta-blocker therapy for dynamic left-ventricular outflow tract obstruction. Int J Cardiol. 2002;86:199–205. doi: 10.1016/s0167-5273(02)00312-1. [DOI] [PubMed] [Google Scholar]
- 15.Vieira ML, Silva Filho RM, Brito Filho FS, Leal SB, Lira Filho EB, Fischer CH, de Souza JA, Perin MA. Selective contrast echocardiography in percutaneous transluminal septal myocardial ablation in an elderly patient with left ventricular concentric hypertrophy. Echocardiography. 2003;20:563–566. doi: 10.1046/j.1540-8175.2003.03096.x. [DOI] [PubMed] [Google Scholar]
- 16.Yalcin F, Yigit F, Erol T, Baltali M, Korkmaz ME, Muderrisoglu H. Effect of dobutamine stress on basal septal tissue dynamics in hypertensive patients with basal septal hypertrophy. J Hum Hypertens. 2006;20:628–630. doi: 10.1038/sj.jhh.1002041. [DOI] [PubMed] [Google Scholar]
- 17.de Simone G, Di Lorenzo L, Costantino G, Moccia D, Buonissimo S, de Divitiis O. Supernormal contractility in primary hypertension without left ventricular hypertrophy. Hypertension. 1988;11:457–463. doi: 10.1161/01.hyp.11.5.457. [DOI] [PubMed] [Google Scholar]
- 18.Yalcin F, Yalcin H, Seyfeli E, Akgul F. Stress-induced hypercontractility in patients with hypertension: an interesting imaging finding. Int J Cardiol. 2010;143:e1–3. doi: 10.1016/j.ijcard.2008.11.186. [DOI] [PubMed] [Google Scholar]
- 19.Smart SC, Knickelbine T, Malik F, Sagar KB. Dobutamine-atropine stress echocardiography for the detection of coronary artery disease in patients with left ventricular hypertrophy. Importance of chamber size and systolic wall stress. Circulation. 2000;101:258–263. doi: 10.1161/01.cir.101.3.258. [DOI] [PubMed] [Google Scholar]
- 20.Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation. 2003;108:560–565. doi: 10.1161/01.CIR.0000081775.72651.B6. [DOI] [PubMed] [Google Scholar]
- 21.Nunez J, Zamorano JL, Perez De Isla L, Palomeque C, Almeria C, Rodrigo JL, Corteza J, Banchs J, Macaya C. Differences in regional systolic and diastolic function by Doppler tissue imaging in patients with hypertrophic cardiomyopathy and hypertrophy caused by hypertension. J Am Soc Echocardiogr. 2004;17:717–722. doi: 10.1016/j.echo.2004.03.029. [DOI] [PubMed] [Google Scholar]
- 22.Yalcin F, Shiota M, Greenberg N, Thomas JD, Shiota T. Real time three-dimensional echocardiography evaluation of mitral annular characteristics in patients with myocardial hypertrophy. Echocardiography. 2008;25:424–428. doi: 10.1111/j.1540-8175.2007.00603.x. [DOI] [PubMed] [Google Scholar]
- 23.Yalcin F, Yalcin H, Kucukler N, Abraham TP. Quantitative left ventricular contractility analysis under stress: a new practical approach in follow-up of hypertensive patients. J Hum Hypertens. 2011;25:578–584. doi: 10.1038/jhh.2010.101. [DOI] [PubMed] [Google Scholar]
- 24.Secknus MA, Niedermaier ON, Lauer MS, Marwick TH. Diagnostic and prognostic implications of left ventricular cavity obliteration response to dobutamine echocardiography. Am J Cardiol. 1998;81:1318–1322. doi: 10.1016/s0002-9149(98)00162-3. [DOI] [PubMed] [Google Scholar]
- 25.Sharkey SW, Lesser JR, Zenovich AG, Maron MS, Lindberg J, Longe TF, Maron BJ. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation. 2005;111:472–479. doi: 10.1161/01.CIR.0000153801.51470.EB. [DOI] [PubMed] [Google Scholar]
- 26.Yalcin F, Muderrisoglu H. Takotsubo cardiomyopathy may be associated with cardiac geometric features as observed in hypertensive heart disease. Int J Cardiol. 2009;135:251–252. doi: 10.1016/j.ijcard.2008.03.018. [DOI] [PubMed] [Google Scholar]
- 27.Yalcin F, Yalcin H, Abraham T. Stress-induced regional features of left ventricle is related to pathogenesis of clinical conditions with both acute and chronic stress. Int J Cardiol. 2010;145:367–368. doi: 10.1016/j.ijcard.2010.02.041. [DOI] [PubMed] [Google Scholar]
- 28.Narayanan A, Aurigemma GP, Chinali M, Hill JC, Meyer TE, Tighe DA. Cardiac mechanics in mild hypertensive heart disease: a speckle-strain imaging study. Circ Cardiovasc Imaging. 2009;2:382–390. doi: 10.1161/CIRCIMAGING.108.811620. [DOI] [PubMed] [Google Scholar]
- 29.Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, Black HR, Grimm RH Jr, Messerli FH, Oparil S, Schork MA. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006;354:1685–1697. doi: 10.1056/NEJMoa060838. [DOI] [PubMed] [Google Scholar]
- 30.Plante GE. Predisease biological markers: early diagnosis and prevention of arterial hypertension. Metabolism. 2008;57(Suppl 2):S36–39. doi: 10.1016/j.metabol.2008.07.014. [DOI] [PubMed] [Google Scholar]
- 31.Yalcin F, Kucukler N, Cingolani O, Mbiyangandu B, Sorensen L, Pinherio A, Abraham MR, Abraham TP. Evolution of ventricular hypertrophy and myocardial mechanics in physiological and pathological hypertrophy. J Appl Physiol (1985) 2019;126:354–362. doi: 10.1152/japplphysiol.00199.2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Frielingsdorf J, Franke A, Kuhl HP, Hess OM, Flachskampf FA. Evaluation of septal hypertrophy and systolic function in diseases that cause left ventricular hypertrophy: a 3-dimensional echocardiography study. J Am Soc Echocardiogr. 2001;14:370–377. doi: 10.1067/mje.2001.112674. [DOI] [PubMed] [Google Scholar]
- 33.Angelakos ET. Regional distribution of catecholamines in the dog heart. Circ Res. 1965;16:39–44. doi: 10.1161/01.res.16.1.39. [DOI] [PubMed] [Google Scholar]
- 34.Kawano H, Okada R, Yano K. Histological study on the distribution of autonomic nerves in the human heart. Heart Vessels. 2003;18:32–39. doi: 10.1007/s003800300005. [DOI] [PubMed] [Google Scholar]
- 35.Yalcin F, Topaloglu C, Kucukler N, Ofgeli M, Abraham TP. Could early septal involvement in the remodeling process be related to the advance hypertensive heart disease? Int J Cardiol Heart Vasc. 2015;7:141–145. doi: 10.1016/j.ijcha.2015.04.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Cicala S, de Simone G, Wachtell K, Gerdts E, Boman K, Nieminen MS, Dahlof B, Devereux RB. Clinical impact of ‘in-treatment’ wall motion abnormalities in hypertensive patients with left ventricular hypertrophy: the LIFE study. J Hypertens. 2008;26:806–812. doi: 10.1097/HJH.0b013e3282f4b3a9. [DOI] [PubMed] [Google Scholar]
- 37.Caselli S, Pelliccia A, Maron M, Santini D, Puccio D, Marcantonio A, Pandian NG, De Castro S. Differentiation of hypertrophic cardiomyopathy from other forms of left ventricular hypertrophy by means of three-dimensional echocardiography. Am J Cardiol. 2008;102:616–620. doi: 10.1016/j.amjcard.2008.04.033. [DOI] [PubMed] [Google Scholar]
- 38.Gottdiener JS, Brown J, Zoltick J, Fletcher RD. Left ventricular hypertrophy in men with normal blood pressure: relation to exaggerated blood pressure response to exercise. Ann Intern Med. 1990;112:161–166. doi: 10.7326/0003-4819-112-3-161. [DOI] [PubMed] [Google Scholar]
- 39.Yalcin F, Abraham TP, Gottdiener JS. Letter by Yalcin et al regarding article, “Left ventricular wall thickness and the presence of asymmetric hypertrophy in healthy young army recruits: data from the LARGE Heart Study”. Circ Cardiovasc Imaging. 2013;6:e28. doi: 10.1161/CIRCIMAGING.113.000720. [DOI] [PubMed] [Google Scholar]
- 40.Lee PT, Dweck MR, Prasher S, Shah A, Humphries SE, Pennell DJ, Montgomery HE, Payne JR. Left ventricular wall thickness and the presence of asymmetric hypertrophy in healthy young army recruits: data from the LARGE heart study. Circ Cardiovasc Imaging. 2013;6:262–267. doi: 10.1161/CIRCIMAGING.112.979294. [DOI] [PubMed] [Google Scholar]
- 41.Wolthuis RA, Froelicher VF Jr, Fischer J, Triebwasser JH. The response of healthy men to treadmill exercise. Circulation. 1977;55:153–157. doi: 10.1161/01.cir.55.1.153. [DOI] [PubMed] [Google Scholar]
- 42.Korhonen PE, Kautiainen H, Jarvenpaa S, Kantola I. Target organ damage and cardiovascular risk factors among subjects with previously undiagnosed hypertension. Eur J Prev Cardiol. 2014;21:980–988. doi: 10.1177/2047487312474530. [DOI] [PubMed] [Google Scholar]
- 43.Kucukler N, Yalcin F, Abraham TP, Garcia MJ. Stress induced hypertensive response: should it be evaluated more carefully? Cardiovasc Ultrasound. 2011;9:22. doi: 10.1186/1476-7120-9-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Malek LA, Czajkowska A, Mroz A, Witek K, Barczuk-Falecka M, Nowicki D, Postula M, Werys K. Left ventricular hypertrophy in middle-aged endurance athletes: is it blood pressure related? Blood Press Monit. 2019;24:110–113. doi: 10.1097/MBP.0000000000000377. [DOI] [PubMed] [Google Scholar]
- 45.Yalcin F, Yalcin H, Abraham TP. Exercise hypertension should be recalled in basal septal hypertrophy as the early imaging biomarker in patients with stressed heart morphology. Blood Press Monit. 2020;25:118–119. doi: 10.1097/MBP.0000000000000429. [DOI] [PubMed] [Google Scholar]
- 46.Yalcin F, Abraham R, Abraham TP. Myocardial aspects in aortic stenosis and functional increased afterload conditions in patients with stressed heart morphology. Ann Thorac Cardiovasc Surg. 2021;27:332–334. doi: 10.5761/atcs.lte.21-00035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Madaric J, Bartunek J, Verhamme K, Penicka M, Van Schuerbeeck E, Nellens P, Heyndrickx GR, Wijns W, Vanderheyden M, De Bruyne B. Hyperdynamic myocardial response to beta-adrenergic stimulation in patients with chest pain and normal coronary arteries. J Am Coll Cardiol. 2005;46:1270–1275. doi: 10.1016/j.jacc.2005.06.052. [DOI] [PubMed] [Google Scholar]
- 48.Come PC, Bulkley BH, Goodman ZD, Hutchins GM, Pitt B, Fortuin NJ. Hypercontractile cardiac states simulating hypertrophic cardiomyopathy. Circulation. 1977;55:901–908. doi: 10.1161/01.cir.55.6.901. [DOI] [PubMed] [Google Scholar]
- 49.Hinderliter AL, Light KC, Willis PW. Patients with borderline elevated blood pressure have enhanced left ventricular contractility. Am J Hypertens. 1995;8:1040–1045. doi: 10.1016/0895-7061(95)00256-1. [DOI] [PubMed] [Google Scholar]
- 50.Yalcin F, Kucukler N, Cingolani O, Mbiyangandu B, Sorensen Lars L, Pinheiro Aurelio C, Abraham MR, Abraham Theodore P. Intracavitary gradients in mice with early regional remodeling at the compensatory hyperactive stage prior to LV tissue dysfunction. J Am Coll Cardiol. 2020;75:1585. [Google Scholar]
- 51.Iskandrian AS, Heo J. Exaggerated systolic blood pressure response to exercise: a normal variant or a hyperdynamic phase of essential hypertension? Int J Cardiol. 1988;18:207–221. doi: 10.1016/0167-5273(88)90166-0. [DOI] [PubMed] [Google Scholar]
- 52.Gorantla RS, Ahmed S, Voruganti D, Menzies DJ. Hyperdynamic left ventricle on radionuclide myocardial perfusion imaging (RNMPI): a marker of diastolic dysfunction in patients presenting with dyspnea on exertion. Int J Cardiol Heart Vasc. 2015;9:43–47. doi: 10.1016/j.ijcha.2015.01.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Yalcin F, Schindler T, Abraham TP. Hypertension should be ruled out in patients with hyperdynamic left ventricle on radionuclide myocardial perfusion imaging, diastolic dysfunction and dyspnea on exertion. Int J Cardiol Heart Vasc. 2015;7:149–150. doi: 10.1016/j.ijcha.2015.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Galderisi M, Caso P, Severino S, Petrocelli A, De Simone L, Izzo A, Mininni N, de Divitiis O. Myocardial diastolic impairment caused by left ventricular hypertrophy involves basal septum more than other walls: analysis by pulsed Doppler tissue imaging. J Hypertens. 1999;17:685–693. doi: 10.1097/00004872-199917050-00013. [DOI] [PubMed] [Google Scholar]
- 55.Kuruvilla S, Janardhanan R, Antkowiak P, Keeley EC, Adenaw N, Brooks J, Epstein FH, Kramer CM, Salerno M. Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone. JACC Cardiovasc Imaging. 2015;8:172–180. doi: 10.1016/j.jcmg.2014.09.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation. 1993;88:993–1003. doi: 10.1161/01.cir.88.3.993. [DOI] [PubMed] [Google Scholar]
- 57.Laviades C, Varo N, Fernandez J, Mayor G, Gil MJ, Monreal I, Diez J. Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation. 1998;98:535–540. doi: 10.1161/01.cir.98.6.535. [DOI] [PubMed] [Google Scholar]
- 58.Lopez B, Querejeta R, Varo N, Gonzalez A, Larman M, Martinez Ubago JL, Diez J. Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation. 2001;104:286–291. doi: 10.1161/01.cir.104.3.286. [DOI] [PubMed] [Google Scholar]
- 59.Tan YT, Wenzelburger F, Lee E, Heatlie G, Frenneaux M, Sanderson JE. Abnormal left ventricular function occurs on exercise in well-treated hypertensive subjects with normal resting echocardiography. Heart. 2010;96:948–955. doi: 10.1136/hrt.2009.185181. [DOI] [PubMed] [Google Scholar]
- 60.Wachtell K, Gerdts E, Palmieri V, Olsen MH, Nieminen MS, Papademetriou V, Boman K, Dahlof B, Aurigemma GP, Rokkedal JE, Devereux RB. In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study. J Hypertens. 2010;28:1541–1546. doi: 10.1097/HJH.0b013e328339f943. [DOI] [PubMed] [Google Scholar]
- 61.Barasch E, Gottdiener JS, Aurigemma G, Kitzman DW, Han J, Kop WJ, Tracy RP. Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study. Circ Heart Fail. 2009;2:303–310. doi: 10.1161/CIRCHEARTFAILURE.108.828343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Gaasch WH, Aurigemma GP. CMR imaging of extracellular volume and myocardial strain in hypertensive heart disease. JACC Cardiovasc Imaging. 2015;8:181–183. doi: 10.1016/j.jcmg.2014.12.002. [DOI] [PubMed] [Google Scholar]

